Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation

Multiple Sclerosis

Volumn 13, Issue 3, 2007, Pages 369-375

  Woolmore, J A ^a   Stone, M ^a   Pye, E M ^a   Partridge, J M ^a   Boggild, M ^b   Young, C ^a   Jones, P W ^c   Fryer, A A ^a   Hawkins, C P ^a   Strange, R C ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

Disability evaluation; Epidemiology; Multiple sclerosis; Sex factors; Skin type; Ultraviolet rays

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; OUTCOME ASSESSMENT; PATHOGENESIS; QUESTIONNAIRE; RADIATION EXPOSURE; SEX DIFFERENCE; SKIN PIGMENTATION; ULTRAVIOLET RADIATION;

ADULT; AGE OF ONSET; DISABILITY EVALUATION; DISABLED PERSONS; ENVIRONMENTAL EXPOSURE; FEMALE; HELIOTHERAPY; HUMANS; MALE; MULTIPLE SCLEROSIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SKIN; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 34248175780     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245850607192     Document Type: Article

References (31)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359: 1221-31.
2. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-46.
3. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand 1975; 51: 110-36.
4. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand 1960; 35: 132-47.
5. van der Mei I, Ponsonby AL, Blizzard L, Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20: 168-74.
6. van der Mei I, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMI 2003; 327: 316.
7. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63: 565-68.
8. Nashold FE, Hoag KA, Goverman J, Hayes CE. Rag-1-dependent cells are necessary for 1,25-dihydroxy-vitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 2001; 119: 16-29.
9. Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Braga M et al. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. J Biol Regul Homeost Agents 2004; 18: 9-17.
10. Hayes CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 199 7; 216: 21-27.
11. Nashold FE, Miller DJ, Hayes CE. 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2000; 103: 171-79.
12. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134: 128-32.
13. Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48: 271-72.
14. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994; 44: 1687-92.
15. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982; 1: 74-76.
16. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
18. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer Sj, Vukusic S et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-51.
19. Luscombe Cj, Fryer AA, French ME, Liu S, Saxby MF, Jones PW et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 2001; 358: 641-42.
20. Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, Mann CL et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 2004; 62: 2323-25.
21. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005; 330: 120.
22. Rampen FH, Fleuren BA, de Boo TM, Lemmens WA. Unreliability of self-reported burning tendency and tanning ability. Arch Dermatol 1988; 124: 885-88.
23. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006; 129: 595-605.
24. Tomassini V, Paolillo A, Russo P, Giugni E, Prosperini L, Gasperini C et al. Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis. J Neural 2006; 253: 287-93.
25. Spach KM, Hayes CE. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175: 4119-26.
26. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 2006; 66: 172-77.
27. Broekmans WM, Vink AA, Boelsma E, Klopping-Ketelaars WA, Tijburg LB, van't Veer P et al. Determinants of skin sensitivity to solar irradiation. Eur J Clin Nutr 2003; 57: 1222-29.
28. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW et al. Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. Carcinogenesis 2003; 24: 711-17.
29. Ziegler AG, Baumgartl Hj, Ede G, Held M, Vogt HJ, Kolb HJ et al. Low-pigment skin type and predisposition for development of type I diabetes. Diabetes Care 1990; 13: 529-31.
30. Friedman AP. Do hyporesponsive genetic variants of the melanocortin 1 receptor contribute to the etiology of multiple sclerosis? Med Hypoth 2004; 62: 49-52.
31. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races? Neurology 2006; 66: 1235-40.